Laser showdown: which works best for acne scars in asian skin?
NCT ID NCT07153679
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tested two different lasers on 38 people with atrophic acne scars. Each person received one laser on one side of the face and the other laser on the other side. The goal was to see which laser improved scars more and caused fewer side effects like dark spots.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 1064-nm Nd:YAG picosecond laser and 1927-nm fractional thulium laser
- What this could lead to
- If one laser proves better, it could offer a more effective and safer option for reducing acne scars in people with darker skin tones.
- What could go wrong
- This is a small, completed trial with only 38 participants. Results may not apply to everyone, and individual responses to lasers can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
38 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Aug 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged between 18 and 40. * Symmetrical atrophic acne scars on both sides of the face. Exclusion Criteria: * Uncontrolled active acne. * Pregnant and lactating women. * Infectious skin diseases at the treatment site. * Have taken retinoid drugs orally within the past 6 months. * Photosensitive individuals or those who have used photosensitive drugs within 2 weeks. * Keloid constitution.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acne scar are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The second affiliated hospital of Xi'an Jiaotong University
Xi’an, Shanxi, 710000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.